Bioequivalence of Two Oral Fluconazole Formulations in Healthy Subjects: a Single Dose, Open-Label, Randomized, Two-Period Crossover Study

  • Palma-Aguirre J
  • Gamboa M
  • Castro-Sandoval T
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: Fluconazole is a triazole antifungal agent labeled for use in the treatment of oropharyngeal and esoph-ageal candidiasis and cryptococcal meningitis, marketed in Mexico in several generic trade names.

Cite

CITATION STYLE

APA

Palma-Aguirre, J. A., Gamboa, M. L., & Castro-Sandoval, T. de J. (2010). Bioequivalence of Two Oral Fluconazole Formulations in Healthy Subjects: a Single Dose, Open-Label, Randomized, Two-Period Crossover Study. Journal of Bioequivalence & Bioavailability, 02(02). https://doi.org/10.4172/jbb.1000026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free